Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis

Ichiro Tojima, Hideaki Kouzaki, Shino Shimizu, Takao Ogawa, Masahiko Arikata, Hirohito Kita, Takeshi Shimizu

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

ILC2s represent a critical innate cellular source of type 2 cytokines and may play important roles in various diseases. We examined the role of ILC2s in the pathogenesis of two subgroups of CRSwNP: ECRS and non-ECRS. We analyzed the prevalence of ILC2s in sinonasal tissues and in blood from patients with ECRS, non-ECRS, CRSsNP, and control. The prevalence of ILC2s in nasal tissues was higher in patients with ECRS as compared to those with non-ECRS or CRSsNP. The prevalence of blood ILC2s was not different between patients with ECRS and non-ECRS. The prevalence of blood ILC2s was higher in patients with allergic rhinitis and elevated serum IgE levels. Alternaria-induced IL-33 secretion was increased in nasal epithelial cells derived from patients with ECRS as compared to those from patients with non-ECRS or CRSsNP. ILC2s may be involved in the pathogenesis of CRSwNP, in particular in patients with tissue eosinophilia (i.e., ECRS).

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalClinical Immunology
Volume170
DOIs
StatePublished - Sep 1 2016

Keywords

  • Allergic rhinitis
  • Alternaria
  • Asthma
  • Eosinophilic chronic rhinosinusitis
  • Group 2 innate lymphoid cells
  • IL-33

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis'. Together they form a unique fingerprint.

Cite this